What is the New Alternative to Statins? Discover PCSK9 Inhibitors

Explore the alternatives to statins, including PCSK9 inhibitors like Repatha and Praluent, for lowering LDL cholesterol effectively.

336 views

A new alternative to statins is PCSK9 inhibitors like evolocumab (Repatha) and alirocumab (Praluent). These are injectable medications that help lower LDL cholesterol levels. They work by inhibiting a protein that interferes with the liver’s ability to remove LDL cholesterol from the blood. Consult your healthcare provider to determine if this option is suitable for you.

FAQs & Answers

  1. What are PCSK9 inhibitors? PCSK9 inhibitors are injectable medications that help lower LDL cholesterol levels by blocking a protein that affects cholesterol removal by the liver.
  2. How do PCSK9 inhibitors compare to statins? PCSK9 inhibitors offer a different mechanism of action than statins and may be prescribed for individuals who cannot tolerate statins or require additional cholesterol lowering.
  3. Who should consider PCSK9 inhibitors? Individuals with high LDL cholesterol who do not achieve target levels with statins or who are statin intolerant may consider PCSK9 inhibitors after consulting their healthcare provider.
  4. Are there side effects of PCSK9 inhibitors? Like all medications, PCSK9 inhibitors can have side effects. Consult with your healthcare provider for detailed information tailored to your health history.